Terzi, C. Et Al. 2020. Randomized controlled trial of 8 weeks' vs 12 weeks' interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer. COLORECTAL DISEASE , no.3 , 279-288.

Terzi, C., Bingul, M., Arslan, N. C., Ozturk, E., Canda, A. E., IŞIK, Ö., ... Yilmazlar, T.(2020). Randomized controlled trial of 8 weeks' vs 12 weeks' interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer. COLORECTAL DISEASE , no.3, 279-288.

Terzi, C. Et Al. "Randomized controlled trial of 8 weeks' vs 12 weeks' interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer," COLORECTAL DISEASE , no.3, 279-288, 2020

Terzi, C. Et Al. "Randomized controlled trial of 8 weeks' vs 12 weeks' interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer." COLORECTAL DISEASE , no.3, pp.279-288, 2020

Terzi, C. Et Al. (2020) . "Randomized controlled trial of 8 weeks' vs 12 weeks' interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer." COLORECTAL DISEASE , no.3, pp.279-288.

@article{article, author={C. Terzi Et Al. }, title={Randomized controlled trial of 8 weeks' vs 12 weeks' interval between neoadjuvant chemoradiotherapy and surgery for locally advanced rectal cancer}, journal={COLORECTAL DISEASE}, year=2020, pages={279-288} }